Monte Rosa Therapeutics, Inc. (GLUE): SCHEDULE 13D/A filed Mar 19, 2026

Form type

SCHEDULE 13D/A

Filing date

Mar 19, 2026

Accession number

0001072613-26-000294

Filer

Monte Rosa Therapeutics, Inc. (CIK 1826457)